Skip to main content
. 2018 Nov;6(22):444. doi: 10.21037/atm.2018.10.24

Figure 2.

Figure 2

PD-L1 TPS immunohistochemistry analysis (×200 magnification) in cases 1 and 2 using clone 22C3 showed (A) almost 100% and (B) at least 95%, respectively. PD-L1, programmed death-ligand 1; TPS, tumor proportion score.